MM 11253 |
| Katalog-Nr.GC10212 |
MM 11253 ist ein potenter und selektiver RARγ-Antagonist mit einem IC50 von 44 nM. MM 11253 hat eine geringere Hemmung von RARα, RARβ und RXRα. MM 11253 blockiert die wachstumshemmenden Wirkungen von RARγ-selektiven Agonisten.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 345952-44-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MM-11253 is a synthetic, conformationally restricted retinoid that acts as a selective antagonist of retinoic acid receptor γ (RARγ).1 It dose-dependently blocks the ability of RARγ-selective agonists, but not retinoic acid (all-trans retinoic acid; to inhibit the growth of oral squamous cell carcinoma cells in vitro.[1]
Reference:
[1]. Le, Q.T., Dawson, M.I., Soprano, D.R., et al. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids. Oncogene 19(11), 1457-1465 (2000).
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *